WO2019157225A2
|
|
Certain chemical entities, compositions, and methods
|
AU2018385711A1
|
|
Methods of treating cancer
|
EP3497087A1
|
|
Certain chemical entities, compositions, and methods
|
EP3270694A1
|
|
Certain chemical entities, compositions, and methods
|
KR20160090786A
|
|
Certain chemical entities, compositions, and methods
|
WO2014075077A1
|
|
Certain chemical entities, compositions, and methods
|
CN104812389A
|
|
Certain chemical entities, compositions, and methods
|
CN104427873A
|
|
Certain chemical entities, compositions, and methods
|
US2015057277A1
|
|
Certain chemical entities, compositions, and methods
|
US2014343068A1
|
|
Substituted quinoxalines as B-RAF kinase inhibitors
|
WO2013043935A1
|
|
Certain chemical entites, compositions, and methods
|
AU2012308238A1
|
|
Certain chemical entities, compositions, and methods
|
CN107245056A
|
|
Chemical entities, composition and method
|
WO2013023145A1
|
|
Certain chemical entities, compositions, and methods
|